Al Hikma Pharmaceuticals
- 70.100 USD
- 0.000
- 0.00%
Hikma Pharmaceuticals PLC Stock Overview
View Company ProfileStock Summary
| Last Price (USD) | 70.100 |
| Prev. Close | 70.100 |
| Day Range | 0.000 - 0.000 |
| 52WK range | |
| Turnover (M USD) | 0.000 |
| Volume (M) | 0.000 |
| Number of Trades | 0 |
| Market Cap (M USD) | 10,261.195 |
| Change in Market Cap (M USD) | |
| VWAP (USD) | 0.000 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | -- |
| 30D Avg Turnover(M USD) | |
| Outstanding Shares | |
| Free Float Shares | -- |
| Free Float % | -- |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Hikma Pharmaceuticals allowed to conduct due diligence...
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) agreed to allow Hikma Pharmaceuticals Plc to conduct due diligence on the...
Hikma Pharmaceuticals to acquire majority stake in...
Cairo – Mubasher: Galxo Group Limited signed a non-binding term sheet with Hikma Pharmaceuticals Plc for the potential sale of its entire stake of...
Hikma Pharmaceuticals issues $500m Eurobonds
UAE - Mubasher: Hikma Pharmaceuticals, listed on Nasdaq Dubai and the London Stock Exchange, issued five-year Eurobonds worth $500 million with an...
Hikma Pharmaceuticals inks deal to distribute Chiesi’s...
Cairo - Mubasher: Hikma Pharmaceuticals, a global company with local presence in the US, the MENA region, and Europe, has penned a licensing and distribution...
Hikma Pharmaceuticals’ Egypt investments near $300m...
By: Ahmed AllamCairo – Mubasher: Hikma Pharmaceuticals’ investments in the Egyptian market range between $250 million and $300 million, the...
